Copyright
©The Author(s) 2022.
World J Transplant. Oct 18, 2022; 12(10): 313-324
Published online Oct 18, 2022. doi: 10.5500/wjt.v12.i10.313
Published online Oct 18, 2022. doi: 10.5500/wjt.v12.i10.313
Table 2 Differences between panel reactive antibodies (-) and (+) patients
| Parameter | T0 (at renal transplantation) | ||
| PRA(-) | PRA(+) | P value | |
| Age, yr | 45 (13-65) | 47 (14-70) | NS |
| HDV, mo | 82.5 (0-251) | 112 (0-165) | NS |
| Time of cold ischemia, h | 18 (0-30) | 16.5 (0-30.5) | NS |
| Pre-emptive RT, % | 6 (13.6) | 1 (3.6) | NS |
| Acute rejection episode, % | 2 (4.5) | 1 (3.6) | NS |
| ATG administration, % | 5 (11.4) | 7 (25) | NS |
| DGF, % | 7 (15.9) | 4 (14.3) | NS |
- Citation: Vagiotas L, Stangou M, Kasimatis E, Xochelli A, Myserlis G, Lioulios G, Nikolaidou V, Panteli M, Ouranos K, Antoniadis N, Maria D, Papagianni A, Tsoulfas G, Fylaktou A. Effect of panel reactive antibodies on T cell immunity reinstatement following renal transplantation. World J Transplant 2022; 12(10): 313-324
- URL: https://www.wjgnet.com/2220-3230/full/v12/i10/313.htm
- DOI: https://dx.doi.org/10.5500/wjt.v12.i10.313